Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Frequent detection of PIK3CA
mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer
Authors
Keywords
-
Journal
Molecular Oncology
Volume 10, Issue 8, Pages 1330-1343
Publisher
Wiley
Online
2016-07-23
DOI
10.1016/j.molonc.2016.07.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pten loss promotes MAPK pathway dependency in HER2/neu breast carcinomas
- (2016) Saya H. Ebbesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting HER2 for the Treatment of Breast Cancer
- (2015) Mothaffar F. Rimawi et al. Annual Review of Medicine
- Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program
- (2015) Amelie Schramm et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
- (2015) Markus Wallwiener et al. BMC CANCER
- Potential of overcoming resistance to HER2-targeted therapies through the PI3K/Akt/mTOR pathway
- (2015) Sharon T. Wilks BREAST
- The predictive and prognostic role of phosphatase phosphoinositol-3 (PI3) kinase (PIK3CA) mutation in HER2-positive breast cancer receiving HER2-targeted therapy: a meta-analysis
- (2015) Ezzeldin M. Ibrahim et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeted Therapies in HER2-Positive Breast Cancer - a Systematic Review
- (2015) Amelie Schramm et al. Breast Care
- Circulating tumor cell enumeration by the CellSearch system: The clinician’s guide to breast cancer treatment?
- (2015) Nick Beije et al. CANCER TREATMENT REVIEWS
- Diverse expression patterns of the EMT suppressor grainyhead-like 2 (GRHL2) in normal and tumour tissues
- (2015) Sabine Riethdorf et al. INTERNATIONAL JOURNAL OF CANCER
- Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2015) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Reactivation of multipotency by oncogenic PIK3CA induces breast tumour heterogeneity
- (2015) Alexandra Van Keymeulen et al. NATURE
- PIK3CAH1047R induces multipotency and multi-lineage mammary tumours
- (2015) Shany Koren et al. NATURE
- Trastuzumab resistance induces EMT to transform HER2+ PTEN− to a triple negative breast cancer that requires unique treatment options
- (2015) Joseph P. Burnett et al. Scientific Reports
- Comparison of variations detection between whole-genome amplification methods used in single-cell resequencing
- (2015) Yong Hou et al. GigaScience
- Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow
- (2014) Glenn Deng et al. BMC CANCER
- PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer
- (2014) A. Markou et al. CLINICAL CANCER RESEARCH
- Molecular profiling of single circulating tumor cells with diagnostic intention
- (2014) B. Polzer et al. EMBO Molecular Medicine
- Biology, detection, and clinical implications of circulating tumor cells
- (2014) S. A. Joosse et al. EMBO Molecular Medicine
- Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
- (2014) Marta Pestrin et al. Molecular Oncology
- Herceptin Resistance Database for Understanding Mechanism of Resistance in Breast Cancer Patients
- (2014) Sahil Ahmad et al. Scientific Reports
- Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer
- (2013) Xiaoyong Fu et al. BREAST
- HER2 and Breast Cancer Stem Cells: More than Meets the Eye
- (2013) H. Korkaya et al. CANCER RESEARCH
- Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients
- (2013) Helen Schneck et al. Molecular Oncology
- Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study
- (2012) V. Georgoulias et al. ANNALS OF ONCOLOGY
- Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
- (2012) François-Clément Bidard et al. CANCER AND METASTASIS REVIEWS
- Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
- (2012) C. Gasch et al. CLINICAL CHEMISTRY
- A PIK3CA Pyrosequencing-Based Assay that Excludes Pseudogene Interference
- (2011) Christine L. Baker et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- (2010) Tanja Fehm et al. BREAST CANCER RESEARCH AND TREATMENT
- Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer
- (2010) Toru Mukohara CANCER SCIENCE
- Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
- (2010) S. Riethdorf et al. CLINICAL CANCER RESEARCH
- PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer
- (2010) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
- (2009) G. Attard et al. CANCER RESEARCH
- Characterization of circulating tumor cells by fluorescence in situ hybridization
- (2009) Joost F. Swennenhuis et al. CYTOMETRY PART A
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More